Paolo is a healthcare investment and market access professional with more than 15 years of experience in both assessing and supporting access to innovative healthcare technologies. Since 2017, Paolo is EU Director Market Access and Members Relations at the Alliance for Regenerative Medicine (ARM) Between 2012 and 2017 he worked at Deerfield Management, a healthcare investment company, where he was Director of EU Research and Market Access. Prior to that, he worked at Merck Serono for five years, at Kyphon (then Medtronic), and also spent 4 years with the Italian HTA Agency Agenas. Paolo’s interests and expertise are centered around healthcare technology value assessment and maximization, with a particular interest in the early stages of product development. He is an engaged stakeholder in EU and international policy debates around access to cell and gene therapies, health technology assessment convergence, early dialogue activities and value-based pricing/contracting. In addition to his role at ARM, Paolo is also VP Market Access at Alira Health, an healthcare consulting firm.